Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Operating Expenses
Vivos Therapeutics Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Operating Expenses
-$25.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Operating Expenses
-$2.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Expenses
-$1.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Expenses
-$40.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
Cigna Corp
NYSE:CI
|
Operating Expenses
-$16.2B
|
CAGR 3-Years
53%
|
CAGR 5-Years
25%
|
CAGR 10-Years
6%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Expenses
-$2.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
See Also
What is Vivos Therapeutics Inc's Operating Expenses?
Operating Expenses
-25.6m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Operating Expenses amounts to -25.6m USD.
What is Vivos Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-18%
Over the last year, the Operating Expenses growth was 27%. The average annual Operating Expenses growth rates for Vivos Therapeutics Inc have been -4% over the past three years , -18% over the past five years .